Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today two-year follow-up data from the Phase III STARGLO study. After a median follow-up of 24.7 months, data showed a 40 ...

Shieldworkz, a leading cybersecurity innovator, today announced the expansion of its Cyber-Physical System security offerings. This strategic move addresses the evolving threat landscape, increasing ...